Direct assessment of the role of NK cells in autoimmune diabetes.
Considerable indirect evidence implicates participation of natural killer cells (NK) in the pathogenesis of diabetes in BB rats. The most convincing evidence derives from studies showing that anti-CD8 antibody effectively prevents both primary disease onset and autoimmune damage to transplanted islets. However, anti-CD8 treatment depletes both NK and cytotoxic T cells (CTL) since both cell types express the CD8 marker. To study directly the role of NK in diabetic BB rats we used MCA 3.2.3, a monoclonal antibody which selectively depletes normal Lewis rats of NK cells but not CTL. A regimen of ip injected antibody achieved rapid reduction of NK cells in diabetic and nondiabetic BB rats by FACS analysis. NK cell activity remained low in rats treated weekly as evidenced by YAC tumor cell killing. We next studied the effect of NK depletion on disease incidence in diabetes-prone BB rats of which about one half are expected to develop diabetes. Onset and incidence of diabetes in 3.2.3-treated and control antibody-treated aged matched litter mates were equal. These studies suggest that NK cells are not necessary for autoimmune islet destruction in spontaneously diabetic BB rats and support a role for CTL in pathogenesis of the disease.
Shachner
M S
MS
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia 19104.
Markmann
J F
JF
Bassiri
H
H
Kim
J I
JI
Naji
A
A
Barker
C F
CF
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D001327:Autoimmune Diseases / Q000209:etiology* / Q000276:immunology; D018956:CD5 Antigens; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology* / Q000276:immunology; D007694:Killer Cells, Natural / Q000502:physiology*; D008212:Lymphocyte Depletion; D051381:Rats; D011913:Rats, Inbred BB
D015703:Antigens, CD; D018956:CD5 Antigens